Rita Sala

441 total citations
15 papers, 371 citations indexed

About

Rita Sala is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rita Sala has authored 15 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Rita Sala's work include Immunotherapy and Immune Responses (5 papers), Bacteriophages and microbial interactions (4 papers) and RNA Interference and Gene Delivery (4 papers). Rita Sala is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Bacteriophages and microbial interactions (4 papers) and RNA Interference and Gene Delivery (4 papers). Rita Sala collaborates with scholars based in Spain, United States and Switzerland. Rita Sala's co-authors include Esther Vázquez, Ramón Mangues, Ugutz Unzueta, Antonio Villaverde, María Virtudes Céspedes, Patricia Álamo, Alejandro Sánchez‐Chardi, Laura Sánchez‐García, Isolda Casanova and Naroa Serna and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Rita Sala

14 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rita Sala Spain	11	230	132	79	76	66	15	371
Aïda Falgàs Spain	12	206 0.9×	132 1.0×	103 1.3×	87 1.1×	75 1.1×	18	385
Raymond J. Moniz United States	9	167 0.7×	127 1.0×	72 0.9×	34 0.4×	32 0.5×	16	354
Yuanke Li United States	10	226 1.0×	86 0.7×	116 1.5×	102 1.3×	27 0.4×	19	455
Shani Leviatan Ben‐Arye Israel	13	373 1.6×	142 1.1×	33 0.4×	46 0.6×	87 1.3×	24	534
Tom J.M. Molenaar Netherlands	10	192 0.8×	78 0.6×	28 0.4×	36 0.5×	114 1.7×	14	368
Elisabetta Bolli Italy	14	271 1.2×	235 1.8×	200 2.5×	16 0.2×	24 0.4×	28	574
Hervé Nozach France	13	184 0.8×	64 0.5×	72 0.9×	15 0.2×	132 2.0×	23	354
Susan Morey United States	7	207 0.9×	154 1.2×	80 1.0×	27 0.4×	83 1.3×	10	359
Yael Diesendruck Israel	9	244 1.1×	120 0.9×	72 0.9×	69 0.9×	18 0.3×	13	464
Roghaye Arezumand Iran	12	294 1.3×	97 0.7×	84 1.1×	87 1.1×	217 3.3×	21	464

Countries citing papers authored by Rita Sala

Since Specialization

Citations

This map shows the geographic impact of Rita Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Sala more than expected).

Fields of papers citing papers by Rita Sala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Sala. The network helps show where Rita Sala may publish in the future.

Co-authorship network of co-authors of Rita Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Sala. A scholar is included among the top collaborators of Rita Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Sala. Rita Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sala, Rita, et al.. (2024). CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos. International Journal of Molecular Sciences. 25(16). 8590–8590. 3 indexed citations

Sala, Rita, Hector Esquer, Paul Awolade, et al.. (2024). CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. International Journal of Molecular Sciences. 25(23). 13160–13160. 1 indexed citations

Sala, Rita, Christophe Nguyen, Khaled El Cheikh, et al.. (2024). Rhabdomyosarcoma targeting with tuned porous silicon nanoparticles. SHILAP Revista de lepidopterología. 5(7-8).

Uldry, Anne‐Christine, Peter K. Bode, Rita Sala, et al.. (2023). Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. International Journal of Molecular Sciences. 24(3). 2601–2601. 10 indexed citations

Zhou, Qiong, Hector Esquer, Rita Sala, et al.. (2023). HTS discovery of PARP1-HPF1 complex inhibitors in cancer. SLAS DISCOVERY. 28(8). 394–401. 6 indexed citations

Sala, Rita, Naroa Serna, Laura Sánchez‐García, et al.. (2022). GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. Drug Delivery. 29(1). 1384–1397. 30 indexed citations

Sánchez‐García, Laura, Rita Sala, Naroa Serna, et al.. (2020). A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity. Acta Biomaterialia. 113. 584–596. 17 indexed citations

Sala, Rita, Laura Sánchez‐García, Naroa Serna, et al.. (2019). Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4+ colorectal cancer. Acta Biomaterialia. 99. 426–432. 13 indexed citations

López‐Laguna, Hèctor, Rita Sala, Julieta M. Sánchez, et al.. (2019). Nanostructure Empowers Active Tumor Targeting in Ligand‐Based Molecular Delivery. Particle & Particle Systems Characterization. 36(11). 12 indexed citations

10.

Céspedes, María Virtudes, Olivia Cano‐Garrido, Patricia Álamo, et al.. (2019). Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci. Advanced Materials. 32(7). e1907348–e1907348. 46 indexed citations

11.

Sánchez‐García, Laura, Naroa Serna, Patricia Álamo, et al.. (2018). Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs. Journal of Controlled Release. 274. 81–92. 63 indexed citations

12.

Unzueta, Ugutz, María Virtudes Céspedes, Rita Sala, et al.. (2018). Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach. Journal of Controlled Release. 279. 29–39. 29 indexed citations

13.

Céspedes, María Virtudes, Ugutz Unzueta, Anna Aviñó, et al.. (2018). Selective depletion of metastatic stem cells as therapy for human colorectal cancer. EMBO Molecular Medicine. 10(10). 69 indexed citations

14.

Serna, Naroa, María Virtudes Céspedes, Laura Sánchez‐García, et al.. (2017). Peptide‐Based Nanostructured Materials with Intrinsic Proapoptotic Activities in CXCR4⁺ Solid Tumors. Advanced Functional Materials. 27(32). 33 indexed citations

15.

Céspedes, María Virtudes, Ugutz Unzueta, Patricia Álamo, et al.. (2016). Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4 + colorectal cancer models. Nanomedicine Nanotechnology Biology and Medicine. 12(7). 1987–1996. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact